Edition:
United Kingdom

ReShape Lifesciences Inc (RSLS.OQ)

RSLS.OQ on NASDAQ Stock Exchange Capital Market

0.54USD
26 Apr 2018
Change (% chg)

$0.01 (+1.69%)
Prev Close
$0.53
Open
$0.53
Day's High
$0.54
Day's Low
$0.53
Volume
11,727
Avg. Vol
43,182
52-wk High
$6.44
52-wk Low
$0.28

Select another date:

Tue, Apr 24 2018

BRIEF-Bobby Griffin To Retire From Reshape Lifesciences' Board

* RESHAPE LIFESCIENCES - ANNOUNCED THAT BOBBY I. GRIFFIN WILL RETIRE FROM BOARD OF DIRECTORS

BRIEF-Reshape Lifesciences Says Reshape Balloon Granted Registration By National Health Regulation Authority In Kingdom Of Bahrain

* RESHAPE LIFESCIENCES INC - RESHAPE BALLOON GRANTED REGISTRATION BY NATIONAL HEALTH REGULATION AUTHORITY IN KINGDOM OF BAHRAIN

BRIEF-Reshape Lifesciences Reports Qtrly Loss Per Share Of $0.45‍​

* RESHAPE LIFESCIENCES ANNOUNCES FOURTH QUARTER AND YEAR END 2017 FINANCIAL RESULTS

BRIEF-Reshape Lifesciences Announces $6 Million Registered Direct Offering

* RESHAPE LIFESCIENCES ANNOUNCES $6 MILLION REGISTERED DIRECT OFFERING Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

BRIEF-Reshape Lifesciences Reschedules Fourth Quarter And Full Year 2017 Conference Call To April 2, 2018

* RESHAPE LIFESCIENCES ANNOUNCES UPDATE ON INTEGRATION EFFORTS AND RESCHEDULES FOURTH QUARTER AND FULL YEAR 2017 CONFERENCE CALL TO APRIL 2, 2018

BRIEF-ReShape Lifesciences Agrees With Academy Medical To Provide Reshape Balloon To Department Of Defense Facilities

* RESHAPE LIFESCIENCES ANNOUNCES AGREEMENT WITH ACADEMY MEDICAL TO PROVIDE RESHAPE BALLOON AND RESHAPE VBLOC TO DEPARTMENT OF DEFENSE FACILITIES

BRIEF-ReShape Lifesciences Q4 Preliminary Revenue About $795,000

* RESHAPE LIFESCIENCES REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2017 REVENUE

BRIEF-SVLSF IV Reports 14 Pct Passive Stake In Reshape Lifesciences

* SVLSF IV, LLC REPORTS 14 PERCENT PASSIVE STAKE IN RESHAPE LIFESCIENCES AS OF DEC 19 - SEC FILING Source text : (http://bit.ly/2lp7hu7) Further company coverage:

BRIEF-Reshape Lifesciences Inc - ‍Received Order For Reshape Integrated Dual Balloon System From Al Zahrawi ​

* RESHAPE LIFESCIENCES INC - ‍RECEIVED ORDER FOR RESHAPE INTEGRATED DUAL BALLOON SYSTEM FROM AL ZAHRAWI MEDICAL​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

BRIEF-Reshape Lifesciences qtrly loss per share $1.06‍​

* Reshape Lifesciences announces third quarter 2017 financial results

Select another date: